2020Selected References

  • Conradt E, et al. 2019. Prenatal opioid exposure: Neurodevelopmental consequences and future research priorities. Pediatrics 144(3):e20190128.
  • Coulson C, et al. 2019. Association of maternal buprenorphine or methadone dose with fetal growth indices and neonatal abstinence syndrome. Am J Perinatol DOI: 10.1055/s-0039-1694729
  • Dorey A, et al. 2019. Possible buprenorphine toxicity in a breastfeeding neonate. Clin Toxicol. 57:889-890.
  • Gawronski KM, et al. 2014. Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone. SAGE Open Medicine 2:
  • Handal M et al. 2019. Prenatal exposure to opioid maintenance treatment and neonatal outsomes: Nationwide registry studies from the Czech Republic and Norway. Pharmacol Res Perspect 7(5):e00501.
  • Ito, S. 2018. Opioids in breast milk: Pharmacokinetic principles and clinical implications. J Clin Pharmacol 58 Suppl 10:S151-S163.
  • Jansson LM, et al. 2017. Maternal buprenorphine treatment and infant outcome. Drug Alcohol Depen. 180 (November):56-61.
  • Jansson LM, et al. 2016. Maternal buprenorphine maintenance and lactation. J Hum Lact. 32:675-81.
  • Jones H E, et al. 2012. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction 107 (Suppl. 1): 5–27.
  • Jones JD, et al. 2012. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 125(1-2): 8–18.
  • Kacinko S, et al. 2008. Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium with Neonatal Outcomes. Clin Pharmacol Ther. 84(5):604-12.
  • Kallenbach K, et al. 2012. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction 107 (Suppl. 1):45-52.
  • Kocherlakota P Neonatal Abstinence Syndrome. Pediatrics 134(2):e547-61.
  • Mascola MA et al. 2017. Committee Opinion No. 711: Opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 130: e81-e94.
  • Reece-Stremtan S, Marinelli KA 2015. ABM Clinical Protocol #21: Guidelines for Breastfeeding and Substance Use or Substance Use Disorder, Revised 2015. Breastfeed Med 10(3):135-141.
  • Schuckit MA. 2016. Treatment of opioid-use disorders. N Engl J.Med. 375:357–68.
  • Soyka M, 2013. Buprenorphine Use in Pregnant Opioid Users: A Critical Review. CNS Drugs 27(8):653-662.
  • Sundelin-Wahlsten V, Sarman I. 2013. Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy. Acta Paediat 102(5): 544-549.
  • Wiegand SL, et al. 2015. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstet Gynecol. 125(2):363-8.